Comparison of mortality following hospitalisation for ulcerative colitis in Scotland between 1998-2000 and 2007-2009

Alimentary Pharmacology and Therapeutics

Volumn 39, Issue 12, 2014, Pages 1387-1397

  Ventham, N T ^a   Kennedy, N A ^a   Duffy, A ^b   Clark, D N ^b   Crowe, A M ^c   Knight, A D ^d   Nicholls, R J ^e   Satsangi, J ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b HEALTHCARE IMPROVEMENT SCOTLAND   (United Kingdom)

^c Corvus Ltd ^*  (United Kingdom)

^d Evicom Limited   (United Kingdom)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CAUSE OF DEATH; COMPARATIVE STUDY; EMERGENCY MEDICINE; EMERGENCY SURGERY; FEMALE; GROUPS BY AGE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; SEX DIFFERENCE; STANDARDIZED MORTALITY RATIO; TIME OF DEATH; ULCERATIVE COLITIS; UNITED KINGDOM;

ADULT; AGE FACTORS; AGED; COLITIS, ULCERATIVE; COMORBIDITY; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SCOTLAND;

EID: 84901504773     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12750     Document Type: Article

References (37)

1. Burisch J, Pedersen N, Cukovic-Cavka S, et al,. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut 2013; 304636: 1-10.
2. Molodecky NA, Soon IS, Rabi DM, et al,. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: e42.
3. Royal College of Physicians. Report of the results for the national clinical audit of adult inflammatory bowel disease inpatient care in Scotland, 2012.
4. Selinger CP, Leong RW,. Mortality from inflammatory bowel diseases. Inflamm Bowel Dis 2012; 18: 1566-72.
5. Kaplan GG, McCarthy EP, Ayanian JZ, et al,. Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis. Gastroenterology 2008; 134: 680-7.
6. Roberts SE, Williams JG, Yeates D, et al,. Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn's disease: record linkage studies. BMJ 2007; 335: 1033.
7. Nicholls RJ, Clark DN, Kelso L, et al,. Nationwide linkage analysis in Scotland implicates age as the critical overall determinant of mortality in ulcerative colitis. Aliment Pharmacol Ther 2010; 31: 1310-21.
8. Kennedy NA, Clark DN, Bauer J, et al,. Nationwide linkage analysis in Scotland to assess mortality following hospital admission for Crohn's disease: 1998-2000. Aliment Pharmacol Ther 2012; 35: 142-53.
9. Ricci C, Lanzarotto F, Lanzini A,. The multidisciplinary team for management of inflammatory bowel diseases. Dig Liver Dis 2008; 40 (Suppl. 2): S285-8.
10. Chang KH, Burke JP, Coffey JC,. Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: a systematic review and meta-analysis. Int J Colorectal Dis 2013; 28: 287-93.
11. Laharie D, Bourreille A, Branche J, et al,. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Lancet 2012; 380: 1909-15.
12. Ananthakrishnan AN, McGinley EL, Saeian K, et al,. Laparoscopic resection for inflammatory bowel disease: outcomes from a nationwide sample. J Gastrointest Surg 2010; 14: 58-65.
13. Vandenbroucke JP, von Elm E, Altman DG, et al,. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology 2007; 18: 805-35.
14. The Scottish Government. Scottish Index of Multiple Deprivation (SMID), 2012.
15. Boyle P, Parkin DM,. Cancer registration: principles and methods. Statistical methods for registries. IARC Sci Publ 1991; 95: 126-58.
16. Kang JY, Elders A, Majeed A, et al,. Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland 1982-2002. Aliment Pharmacol Ther 2006; 24: 65-79.
17. Ellis H, Moran BJ, Thompson JN, et al,. Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet 1999; 353: 1476-80.
18. McMahon AJ, Fischbacher CM, Frame SH, et al,. Impact of laparoscopic cholecystectomy: a population-based study. Lancet 2000; 356: 1632-7.
19. Henderson P, Hansen R, Cameron FL, et al,. Rising incidence of pediatric inflammatory bowel disease in Scotland. Inflamm Bowel Dis 2012; 18: 999-1005.
20. Bernstein CN, Wajda A, Blanchard JF,. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clin Gastroenterol Hepatol 2008; 6: 41-5.
21. Dorn SD, Sandler RS,. Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis. Am J Gastroenterol 2007; 102: 662-7.
22. Fumery M, Xiaocang C, Dauchet L, et al,. Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies. J Crohns Colitis 2014; 8: 469-79.
23. Sewell JL, Yee HF,. 13-year mortality trends among hospitalized patients with inflammatory bowel disease. BMC Gastroenterol 2012; 12: 79.
24. Jess T, Frisch M, Simonsen J,. Trends in overall and cause-specific mortality among patients with inflammatory bowel disease from 1982 to 2010. Clin Gastroenterol Hepatol 2013; 11: 43-8.
25. Ananthakrishnan AN, McGinley EL, Binion DG,. Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations. Inflamm Bowel Dis 2009; 15: 182-9.
26. Ha CY, Katz S,. Clinical outcomes and management of inflammatory bowel disease in the older patient. Curr Gastroenterol Rep 2013; 15: 310.
27. Travis SP, Farrant JM, Ricketts C, et al,. Predicting outcome in severe ulcerative colitis. Gut 1996; 38: 905-10.
28. Mowat C, Cole A, Windsor A, et al,. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011; 60: 571-607.
29. Travis SPL, Schnell D, Krzeski P, et al,. Reliability and initial validation of the ulcerative colitis endoscopic index of severity. Gastroenterology 2013; 145: 987-95.
30. Dinesen LC, Walsh AJ, Protic MN, et al,. The pattern and outcome of acute severe colitis. J Crohns Colitis 2010; 4: 431-7.
31. Costa J, Magro F, Caldeira D, et al,. Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis 2013; 19: 2098-110.
32. Travis S, Satsangi J, Lémann M,. Predicting the need for colectomy in severe ulcerative colitis: a critical appraisal of clinical parameters and currently available biomarkers. Gut 2011; 60: 3-9.
33. ISD Scotland. Assessment of SMR01 Data Scotland Report, May 2012.
34. National Health Service Central Register (NHSCR) patient movements. Net migration, Scotland, 1951-2012, 2013.
35. Scottish Medicines Consortium. Scottish Medicines Consortium infliximab 100 mg powder for concentrate for solution for Ulcerative colitis, 2009.
36. Charlson ME, Pompei P, Ales KL, et al,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
37. Elixhauser A, Steiner C, Harris DR, et al,. Comorbidity measures for use with administrative data. Med Care 1998; 36: 8-27.